Deciphering enhancer regulation in stem cells
Deciphering enhancer regulation in stem cells
批准号:
10711332
负责人:
Kaixiang Cao
金额:
$40.25万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2028-07-31
关键词:
AreaCellsChromatinDevelopmentDiseaseEmbryonic DevelopmentEnhancersEnzymesEpigenetic ProcessGene ExpressionGene Expression RegulationGenesHealthHigher Order Chromatin StructureHistonesHumanKDM1A geneKnowledgeLaboratoriesMalignant NeoplasmsPathogenesisPhysiological ProcessesPlayPluripotent Stem CellsProteinsReaderRegulationResearchRoleTranscriptional Regulationantagonistdevelopmental diseasehistone demethylasehistone methyltransferasehuman diseaseinsightnovelpluripotencypluripotency factorrecruitself-renewalstem cell differentiationstem cell self renewalstem cells
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The hallmark of pluripotent stem cells (PSCs) is their capability to self-renew and differentiate, which is governed
by the core pluripotency circuitry consisting of pluripotency factors OCT4, SOX2, and NANOG. Enhancers are
fundamental in regulating the spatial and temporal expression of pluripotency genes and lineage specific genes
during cellular differentiation and embryogenesis. Enhancer-regulating epigenetic modifiers play critical roles in
normal physiological processes and human pathogenesis. Epigenetic marks such as H3K4me1 and H3K27ac
are widely believed to regulate the activity and higher-order chromatin structure of enhancers by directly
remodeling local chromatin and/or recruiting reader proteins. However, recent discoveries of catalytic-
independent functions of multiple histone modifiers suggest that these enzymes govern enhancers and stem cell
differentiation via a non-catalytic manner. Despite the importance of epigenetic modifiers in mammalian
development and human diseases, how they sustain stem cell identity and impact human health is poorly
understood. I previously demonstrated that while enhancer activation does not require the catalytic activity of
histone methyltransferase MLL4 in PSCs, it is regulated by the functional antagonism between MLL4 and histone
demethylase LSD1. Using state-of-the-art unbiased approaches, my lab recently unveiled novel mechanisms
underlying the role of enhancer-regulating epigenetic modifiers in PSCs, providing insight into elucidating gene
regulation and cell fate transition. Here, I propose to build two research areas in my laboratory focused on
enhancer-regulating epigenetic modifiers. The first research area will focus on identifying catalytic-independent
functions of LSD1 in governing gene expression and cellular differentiation. The second research area will focus
on determining how MLL4 and its interactors modulate enhancer activity and cell fate transition. I anticipate that
accomplishing the proposed studies will reveal novel mechanisms underlying enhancer regulation, decipher how
stem cell self-renewal and differentiation are governed, and pave the way for understanding the pathogenesis of
diseases driven by enhancer malfunction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploring novel regulatory mechanisms underlying enhancer activation and cell fate transition
-
批准号:10471972
-
项目类别:
-
资助金额:$17.36万
-
财政年份:2020
-
负责人:Kaixiang Cao
-
依托单位:
Exploring novel regulatory mechanisms underlying enhancer activation and cell fate transition
-
批准号:10259871
-
项目类别:
-
资助金额:$24.09万
-
财政年份:2020
-
负责人:Kaixiang Cao
-
依托单位:
Exploring novel regulatory mechanisms underlying enhancer activation and cell fate transition
-
批准号:9891069
-
项目类别:
-
资助金额:$10.16万
-
财政年份:2019
-
负责人:Kaixiang Cao
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: